Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (311-320 of 662) with videos related to

Pageof 67
Sort By:
The American Journal of Pathology|April 5, 2011
Identification of oncostatin M as a STAT5-dependent mediator of bone marrow remodeling in KIT D816V-positive systemic mastocytosisGregor Hoermann, Sabine Cerny-Reiterer, Andrea Perné, et al.
Cells|January 8, 2023
Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph<sup>+</sup> Chronic Myeloid LeukemiaIrina Sadovnik, Daniel Ivanov, Dubravka Smiljkovic, et al.
International Archives of Allergy and Immunology|November 22, 2002
Activation of human mast cells through stem cell factor receptor (KIT) is associated with expression of bcl-2Mehrdad Baghestanian, John-Hendrik Jordan, Hans P Kiener, et al.
Critical Reviews in Oncology/Hematology|September 10, 2011
Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questionsPeter Valent, Günther Gastl, Klaus Geissler, et al.
American Journal of Clinical Pathology|May 23, 2003
Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB categoryMinoo Ghannadan, Friedrich Wimazal, Ingrid Simonitsch, et al.
Journal of Leukocyte Biology|January 15, 2003
Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3Yasamin Majlesi, Puchit Samorapoompichit, Alexander W Hauswirth, et al.
Leukemia Research|March 20, 2013
Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: a multicenter retrospective studyNamiko Okuyama, Wolfgang R Sperr, Katalin Kadar, et al.
Veterinary Immunology and Immunopathology|January 2, 2007
Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cellsLaura Rebuzzi, Michael Willmann, Karoline Sonneck, et al.
American Journal of Cancer Research|January 12, 2022
PI3-kinase inhibition as a strategy to suppress the leukemic stem cell niche in Ph+ chronic myeloid leukemiaYüksel Filik, Karin Bauer, Emir Hadzijusufovic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2011
Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1Anna Gieras, Petra Cejka, Katharina Blatt, et al.
Pageof 67

Showing results (311-320 of 662) with videos related to

Sort By:
Pageof 67
The American Journal of Pathology|April 5, 2011
Identification of oncostatin M as a STAT5-dependent mediator of bone marrow remodeling in KIT D816V-positive systemic mastocytosisGregor Hoermann, Sabine Cerny-Reiterer, Andrea Perné, et al.
Cells|January 8, 2023
Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph<sup>+</sup> Chronic Myeloid LeukemiaIrina Sadovnik, Daniel Ivanov, Dubravka Smiljkovic, et al.
International Archives of Allergy and Immunology|November 22, 2002
Activation of human mast cells through stem cell factor receptor (KIT) is associated with expression of bcl-2Mehrdad Baghestanian, John-Hendrik Jordan, Hans P Kiener, et al.
Critical Reviews in Oncology/Hematology|September 10, 2011
Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questionsPeter Valent, Günther Gastl, Klaus Geissler, et al.
American Journal of Clinical Pathology|May 23, 2003
Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB categoryMinoo Ghannadan, Friedrich Wimazal, Ingrid Simonitsch, et al.
Journal of Leukocyte Biology|January 15, 2003
Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3Yasamin Majlesi, Puchit Samorapoompichit, Alexander W Hauswirth, et al.
Leukemia Research|March 20, 2013
Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: a multicenter retrospective studyNamiko Okuyama, Wolfgang R Sperr, Katalin Kadar, et al.
Veterinary Immunology and Immunopathology|January 2, 2007
Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cellsLaura Rebuzzi, Michael Willmann, Karoline Sonneck, et al.
American Journal of Cancer Research|January 12, 2022
PI3-kinase inhibition as a strategy to suppress the leukemic stem cell niche in Ph+ chronic myeloid leukemiaYüksel Filik, Karin Bauer, Emir Hadzijusufovic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2011
Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1Anna Gieras, Petra Cejka, Katharina Blatt, et al.
Pageof 67